
20222 min read
Medical Article
A 59-year-old male with a confirmed diagnosis of small-cell lung cancer (SCLC). He had progressive disease even after four cycles of chemotherapy and 21 cycles of radiation. He was therefore started on immunotherapy with nivolumab every 2 weeks and ipilimumab every 6 weeks. (1) After 4 months of starting immunotherapy, he reported extreme fatigue,

Right Medial Nerve Facilitation During SCLC Immunotherapy
848 Reached17 Comments
Similar Content

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Black Lesion in Old Female
1963 Reached5 Comments11 Likes

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1004 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes

Management of Metastatic Prostate Cancer
1035 Reached5 Comments2 Likes